Enhancing the predictability of drug toxicity and efficacy

There is an unmet clinical need in drug development for in vitro models that reduce the risk of drug-induced toxicity and late-stage drug attrition.

In an upcoming webinar, which will be hosted on May 26, two expert speakers will be discussing how researchers can enhance the predictability of pre-clinical drug development.

This webinar, Enhancing the predictability of preclinical development, hosted by DDW and supported by PerkinElmer, will take place on 26 May at 4PM BST;  8AM PDT; 11 AM EDT; 5PM CEST.

Dr. Seyoum Ayehunie, Vice President, Scientific Research and Development, MatTek Corporation, will discuss the functionality and limitations of a novel in vitro 3D primary human cell-based tissue model for drug toxicity and efficacy studies.

This talk will be followed by a presentation from Dr. Hyelim Cho, Group Lead, Immunogenicity, Global DMPK Oncology and Rare Diseases, Takeda Pharmaceuticals, (pictured),  who will explain why developing a predictive pre-clinical assay is key to success in immuno-oncology drug development.

Key Learning Objectives:

  • How to evaluate models to establish robust and reliable preclinical investigation of drug candidates prior to entering clinical trials
  • How to gain an understanding of the advancements in preclinical model systems and assays
  • What to consider from the latest innovations and impact on bioanalytical assays

Who Should Attend:

  • Preclinical development scientists
  • Pharmacologists
  • Toxicologists
  • Bioanalytical assay development scientists
  • Analytical scientists

Register here

 

Suggested Reading

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free